UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,205,660
-$307,006 QoQ
Shares Held
320,566
-13.1% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 316 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,988 | $282,049,632 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,832,465 | $129,843,910 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
218,164 | $118,207,795 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
504,233 | $84,983,427 | |
| 5 | VTRS |
Viatris Inc
|
4,293,757 | $68,184,856 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
482,743 | $53,555,505 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,510,327 | $37,169,144 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
425,977 | $14,768,619 |
All Filings in BCRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,205,660 | 320,566 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,512,666 | 368,978 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,955,050 | 378,853 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,996,073 | 394,740 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,200,038 | 691,969 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,363,493 | 448,466 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,016,352 | 401,111 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,960,426 | 389,530 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,675,337 | 432,903 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,254,625 | 246,974 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,479,372 | 246,974 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,674,849 | 236,561 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,665,387 | 236,561 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,972,915 | 236,561 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,338,472 | 203,700 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,567,538 | 203,773 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,121,510 | 200,521 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,758,497 | 231,150 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,829,871 | 204,323 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,511,313 | 174,761 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,697,846 | 233,893 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,373,808 | 233,413 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $3,994,371 | 1,161,155 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,527,096 | 1,161,155 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $232,570 | 116,285 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||